Saudi Chemical agrees $27mln GlaxoSmithKline manufacturing deal

Five year deal will bring pharma manufacturing to Saudi Arabia

  
Quality Engineer inspecting product in production process at medical industry. Image used for illustrative purpose.

Quality Engineer inspecting product in production process at medical industry. Image used for illustrative purpose.

Getty Images
 
RIYADH: Saudi Chemical Company Holding (SCCH) has struck a deal with GlaxoSmithKline to make pharmaceutical products in the Kingdom.


SCCH unit AJA Pharmaceutical Industries will team up with GlaxoSmithKline Consumer Healthcare Saudi in a five-year production deal worth SR100 million ($27 million), the company said in a Saudi stock exchange filing on Thursday.

The new partnership would help create more jobs for Saudis in the Kingdom’s pharmaceuticals sector said SCCH CEO Thamer Al-Muhid,

“Our mission is to be the partner of choice,” he said.

Saudi Arabia aims to diversify its economy away from oil by adding more high value jobs at home and replacing imports with domestic manufacturing in key sectors such as pharmaceuticals.

Copyright: Arab News © 2021 All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Business